Biomarker Testing Practices for Non-small Cell Lung Cancer: Survey Insights from South Korean Pathology Laboratories
Biomarker testing is widely implemented in South Korea, with increasing integration of NGS. Despite alignment with international recommendations, systemic and policy reforms are needed to harmonize workflows, reduce variability, and optimize precision oncology.
Authors
- S. S. Kim (ORCID: https://orcid.org/0009-0005-6453-0400)
- D. Kim
- Wan-Seop Kim
- Lucia Kim
Institutions
- Inha University (KR)
- Korea University (KR)
- Konkuk University (KR)
- Korea University Medical Center (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2026-01-30
- DOI
- https://doi.org/10.4143/crt.2025.927
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- International Association for the Study of Lung Cancer
- Seoul National University Bundang Hospital
- Korea University Guro Hospital
- Korea University Medicine
- Konkuk University Medical Center
- Hanyang University
- Chonbuk National University
- Dong-A University
- Konyang University
- Seoul National University
- University of Ulsan
- Yonsei University
- Gyeongsang National University
- Kyung Hee University
- Ewha Womans University
- Gachon University
- Inha University
- Inje University
- Konkuk University
- Korea University
- Sungkyunkwan University
- Chonbuk National University Hospital
- National Health Insurance Service
- Seoul National University Hospital
- CHA University
- NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL
- Korea University Anam Hospital
- Inha University Hospital
- Samsung
- Seoul St. Mary's Hospital, Catholic University of Korea
- Ulsan University Hospital
- Busan Paik Hospital, Inje University
- Incheon St. Mary's Hospital, Catholic University of Korea